Home > Boards > Canadian > Biotechs >

BioSyntech (TSX:BSY)

TSX:BSY RSS Feed
Add TSX:BSY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/17/2010 1:31:04 PM - Followers: 0 - Board type: Free - Posts Today: 0

BST-CarGel PIII Results soon . This stock is flying under Radar .. Positive Final- Data will push this stock over 1$ !! BioSyntech (BSY.TO) Market Cap : 10,5 Mio $ Price : 0,105 $ BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel® Cartilage Repair Device June 17, 2009 http://biosyntech.com/en/investors/press.aspx?ID=111 BST-CarGel http://biosyntech.com/en/expertise/orthopedics/?BST=CarGel Insider http://canadianinsider.com/coReport/allTransactions.php?ticker=bsy Market Potential BST-CarGel® Not yet approved by Health Canada, the FDA or the European authorities BST-CarGel® is aimed at treating focalized cartilage lesions, either from trauma (sports injury or accident) or from secondary osteoarthritis (OA) degeneration. Arthroscopic view of a cartlage lesion The various surgical techniques (microfactures, mosaicplasty, autologous chondrocyte implantation) currently used all have their drawbacks including complicated or multiple surgeries, high cost and/or poor outcomes. Orthopedic surgeons perform 1.6 million of knee arthroscopic procedures each year in the USA. Cartilage lesions are found in a large number of these procedures. Additionally, a number of patients too young for arthroplasty, suffering from secondary osteoarthritic focal lesions due to previous trauma, body weight, mis-alignment of the joint or from a previous meniscal surgery, may be good candidates for BST-CarGel®. Osteoarthritis affects around 10% of the population. In the USA alone, it represents 21 million people, out of whom around 65% suffer from OA of the knee. Cartilage lesions in other joints such as the hip, ankle and the shoulder could potentially benefit from BST-CarGel®. BST-CarGel® will be more cost-effective than the overly-expensive cell-based therapies to address the challenges of the various healthcare systems around the worl
TSX:BSY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#1   BST-CarGel PIII Results soon . This stock is BioSpecialist 02/17/10 01:31:03 PM
PostSubject